Doctorglasses Chain Income Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020
Operating Revenue	1,355	1,190	1,161	951.51	881.1	651.39
Other Revenue	12.68	12.68	14.63	10.72	6.37	4.92
Revenue	1,368	1,203	1,176	962.24	887.47	656.31
Revenue Growth (YoY)	15.38%	2.29%	22.20%	8.43%	35.22%	0.19%
Cost of Revenue	590.64	470.37	442.18	373.9	313.84	212.89
Gross Profit	777.4	732.44	733.69	588.34	573.63	443.42
Selling, General & Admin	626.8	592.02	564.92	498.69	454.23	368.27
Research & Development	2.11	3.08	4.67	-	-	-
Other Operating Expenses	6.84	4.15	4.99	1.91	2.64	1.88
Operating Expenses	636.93	599.58	575.31	501.06	457.35	370.75
Operating Income	140.47	132.86	158.38	87.28	116.28	72.67
Interest Expense	-7.6	-8.61	-7.69	-9.02	-9.09	-1.05
Interest & Investment Income	14.57	16.3	15.24	9.43	9.4	9.74
Currency Exchange Gain (Loss)	-0.77	-0.77	0.52	0.31	0.33	-
Other Non Operating Income (Expenses)	-3.51	-4.61	-3.77	-3.44	-3.5	-3.13
EBT Excluding Unusual Items	143.16	135.16	162.68	84.57	113.42	78.23
Impairment of Goodwill	-12.14	-12.14	-5.3	-	-	-
Gain (Loss) on Sale of Investments	4.49	2.21	4.58	-0.83	-0.39	-0.32
Gain (Loss) on Sale of Assets	0.71	2.35	0.88	2.26	0.59	0.01
Asset Writedown	-1.97	-4.04	-0.14	-0.1	-0.1	-0.17
Other Unusual Items	6.04	5.57	1.44	6.94	7.71	8.04
Pretax Income	140.28	129.12	164.13	92.84	121.24	85.79
Income Tax Expense	30.18	27.8	32.37	18.4	26.74	17.9
Earnings From Continuing Operations	110.1	101.32	131.76	74.44	94.5	67.89
Minority Interest in Earnings	-2.13	2.31	-3.69	1.37	0.28	1.28
Net Income	107.98	103.63	128.06	75.81	94.78	69.17
Net Income to Common	107.98	103.63	128.06	75.81	94.78	69.17
Net Income Growth	-5.25%	-19.08%	68.93%	-20.02%	37.02%	10.93%
Shares Outstanding (Basic)	228	228	225	219	220	219
Shares Outstanding (Diluted)	228	228	225	224	224	219
Shares Change (YoY)	0.33%	1.50%	0.46%	-0.03%	2.14%	0.48%
EPS (Basic)	0.47	0.45	0.57	0.35	0.43	0.32
EPS (Diluted)	0.47	0.45	0.57	0.34	0.42	0.32
EPS Growth	-5.56%	-20.27%	68.15%	-19.99%	34.15%	10.40%
Free Cash Flow	306.75	249.53	259.34	182.13	170.83	76.41
Free Cash Flow Per Share	1.34	1.09	1.15	0.81	0.76	0.35
Dividend Per Share	-	0.208	0.462	0.231	0.385	0.269
Dividend Growth	-	-55.00%	99.96%	-39.99%	42.87%	63.25%
Gross Margin	56.83%	60.89%	62.40%	61.14%	64.64%	67.56%
Operating Margin	10.27%	11.05%	13.47%	9.07%	13.10%	11.07%
Profit Margin	7.89%	8.62%	10.89%	7.88%	10.68%	10.54%
Free Cash Flow Margin	22.42%	20.75%	22.05%	18.93%	19.25%	11.64%
EBITDA	143.48	140.55	172.3	97.85	125.52	78.21
EBITDA Margin	10.49%	11.68%	14.65%	10.17%	14.14%	11.92%
D&A For EBITDA	3.01	7.69	13.92	10.57	9.23	5.54
EBIT	140.47	132.86	158.38	87.28	116.28	72.67
EBIT Margin	10.27%	11.05%	13.47%	9.07%	13.10%	11.07%
Effective Tax Rate	21.51%	21.53%	19.72%	19.82%	22.05%	20.86%
Revenue as Reported	1,368	1,203	1,176	962.24	887.47	656.31
Advertising Expenses	-	7.69	6.98	4.23	2.72	2.04

Source: S&P Global Market Intelligence. Standard template. Financial Sources.